Cite

HARVARD Citation

    Andrés‐Zayas, C. et al. (2021). Clinical utility of targeted next‐generation sequencing for the diagnosis of myeloid neoplasms with germline predisposition. Molecular oncology. 15 (9), pp. 2273-2284. [Online]. 
  
Back to record